VVT Med Inc. (the "Company" or "VVT"), announces that it has made an application to the British Columbia Securities Commission to approve a temporary management cease trade order (the "MCTO") under ...
4d
Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed within days of activation — a signal of strong ...
Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in disease, today announced that multiple abstracts will ...
A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
It’s a big story at first glance: Boston College set a new all-time school record this year for undergraduate applications—just under 40,000—in the midst of a pandemic that has created widespread ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results